Dr Stephen W Wegner, MD | |
109 1st Ave Se, Cut Bank, MT 59427-3208 | |
(406) 450-1754 | |
Not Available |
Full Name | Dr Stephen W Wegner |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Location | 109 1st Ave Se, Cut Bank, Montana |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114088259 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 10600 (Montana) | Primary |
Entity Name | Us Health Dept Of Health & Human Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972694602 PECOS PAC ID: 9638081623 Enrollment ID: O20031106000399 |
News Archive
Taro Pharmaceutical Industries Ltd. reported today that it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Granisetron Hydrochloride Tablets USP, 1 mg (base) ("granisetron tablets").
Acorda Therapeutics, Inc. will present new research data on AMPYRA (dalfampridine) Extended Release Tablets, 10 mg at the 5th Cooperative Meeting of the Consortium of Multiple Sclerosis Centers and Americas Committee for Treatment and Research in Multiple Sclerosis, being held in Orlando, FL, May 29 - June 1.
Sexual harassment remains a pervasive problem in India despite tougher laws enacted more than three years ago after a woman was gang raped on a bus and later died of her injuries, indicates new research by a Michigan State University criminologist.
Some companies offer discounts to healthy employees, but patient advocates fear such wellness programs could be unfair.
New research has determined that patients in the U.S. with hepatitis C virus are twice as likely to not have health insurance coverage compared with those without the disease.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Stephen W Wegner, MD Po Box 1113, Cut Bank, MT 59427-1113 Ph: (406) 450-1754 | Dr Stephen W Wegner, MD 109 1st Ave Se, Cut Bank, MT 59427-3208 Ph: (406) 450-1754 |
News Archive
Taro Pharmaceutical Industries Ltd. reported today that it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Granisetron Hydrochloride Tablets USP, 1 mg (base) ("granisetron tablets").
Acorda Therapeutics, Inc. will present new research data on AMPYRA (dalfampridine) Extended Release Tablets, 10 mg at the 5th Cooperative Meeting of the Consortium of Multiple Sclerosis Centers and Americas Committee for Treatment and Research in Multiple Sclerosis, being held in Orlando, FL, May 29 - June 1.
Sexual harassment remains a pervasive problem in India despite tougher laws enacted more than three years ago after a woman was gang raped on a bus and later died of her injuries, indicates new research by a Michigan State University criminologist.
Some companies offer discounts to healthy employees, but patient advocates fear such wellness programs could be unfair.
New research has determined that patients in the U.S. with hepatitis C virus are twice as likely to not have health insurance coverage compared with those without the disease.
› Verified 8 days ago